Differential yield of universal versus selective drug susceptibility testing of patients with tuberculosis in high-burden countries: a systematic review and meta-analysis

INTRODUCTION: Although universal drug susceptibility testing (DST) is a component of the End-TB Strategy, over 70% of drug-resistant tuberculosis (DR-TB) cases globally remain undetected. This detection gap reflects difficulties in DST scale-up and substantial heterogeneity in policies and implement...

Descripción completa

Detalles Bibliográficos
Autores principales: Svadzian, Anita, Sulis, Giorgia, Gore, Genevieve, Pai, Madhukar, Denkinger, Claudia M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549483/
https://www.ncbi.nlm.nih.gov/pubmed/33037062
http://dx.doi.org/10.1136/bmjgh-2020-003438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549483/
https://www.ncbi.nlm.nih.gov/pubmed/33037062
http://dx.doi.org/10.1136/bmjgh-2020-003438

Ejemplares similares